Thomas Condamine
About Thomas Condamine
Thomas Condamine is the Vice President of Discovery and Translational Sciences at Carisma, specializing in myeloid cell biology and immune-therapy with over 15 years of experience in the field.
Thomas Condamine - Vice President, Discovery and Translational Sciences at Carisma
Thomas Condamine serves as the Vice President of Discovery and Translational Sciences at Carisma. He joined the company in June 2020 and brings over 15 years of expertise in myeloid cell biology across various disease settings, including oncology. With a strong background in immunotherapy and translational sciences, Thomas currently leads correlative studies and biomarker analysis in support of Carisma's clinical trials. Additionally, he oversees the preclinical development efforts, ensuring robust scientific progress in the company's therapeutic initiatives.
Thomas Condamine's Expertise in Myeloid Cell Biology and Immunotherapy
Thomas Condamine possesses over 15 years of experience in myeloid cell biology, particularly in oncology and other disease settings. His expertise spans immune therapy and translational sciences, focusing on early phase development. At Carisma, he leverages his extensive background to lead critical correlative studies and biomarker analyses, underpinning the success of the company's clinical trials. His role also involves steering preclinical development to advance Carisma's research initiatives effectively.
Thomas Condamine's Role and Achievements at Incyte Corporation
Before joining Carisma, Thomas Condamine held a significant position at Incyte Corporation, where he led the translational effort for six large molecules targeting immune checkpoints in early clinical development. His responsibilities included close collaboration with the pre-clinical group to support several programs through IND submission. Thomas's contributions were pivotal in advancing these programs, showcasing his deep understanding and expertise in translational sciences and immune checkpoint biology.
Thomas Condamine's Academic Background in Immunology
Thomas Condamine holds a Master's degree in Immunology from Paris XI University and a PhD in Immunology from Nantes University in France. His academic journey provided him with a strong foundation in immunological principles, which he has applied throughout his career in both basic and translational research. This background supports his current roles and responsibilities in leading scientific and clinical initiatives at Carisma and previously at Incyte Corporation.
Thomas Condamine's Research on Myeloid-Derived Suppressor Cells and Macrophages in Cancer
Thomas Condamine has conducted significant research focused on the study of Myeloid-derived suppressor cells (MDSCs) and macrophage function in cancer. His work at the Moffitt Cancer Center and the Wistar Institute contributed valuable insights into the role of these cells in the tumor microenvironment. These research experiences have equipped him with a comprehensive understanding of myeloid cell biology, directly informing his current work in translational sciences and preclinical development.